Wall Street's main indices experienced gains, led by healthcare stocks hitting record highs and easing oil prices. The Dow Jones rose by 0.97%, while the S&P 500 and Nasdaq also s…
AbbVie is nearing its 52-week high, driven by strong sales of SKYRIZI, its psoriasis and Crohn's disease treatment. However, potential risks to its stock price arise from market c…
In a bold new initiative, the administration seeks to reassure investors that while psychedelic research faces hurdles, their bank accounts will float high above any mental health…
As inflation remains a concern, certain stocks known as Dividend Aristocrats are positioned to thrive. These companies have a history of increasing dividends and are expected to p…